Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
MIC B12 (methylcobalamin-inositol-choline B12) dosing typically ranges from 500–2500 mcg per injection, determined by baseline serum and functional B12 levels, metabolic rate, and clinical objectives. Dose optimization requires baseline biomarker testing and provider oversight to ensure efficacy and safety.
B12 supplementation plays a critical metabolic role in energy production, methylation, and nervous system function. Understanding your individual B12 status—rather than applying generic dosing protocols—supports more precise dosing decisions and better health outcomes with a qualified provider.
Standard MIC B12 Dosing Ranges and Frequency
Clinical dosing for MIC B12 injections typically begins at 500–1000 mcg once weekly, with adjustments based on symptom response and B12 levels. Higher doses (1500–2500 mcg) are sometimes used for individuals with absorption issues, metabolic demands, or deficiency-related symptoms such as fatigue, neuropathy, or cognitive changes.
Frequency depends on individual response and metabolic need. Some patients benefit from weekly injections initially, then transition to biweekly or monthly maintenance. Baseline serum B12, methylmalonic acid (MMA), and homocysteine levels help guide initial dosing and expected response timelines.
Biomarkers That Inform Personalized MIC B12 Dosing
Beyond serum B12 measurement, functional biomarkers reveal true B12 status and help tailor dose. Elevated methylmalonic acid (MMA) and homocysteine indicate functional B12 deficiency even with normal serum levels. These markers guide providers in determining whether standard or higher-dose protocols are appropriate.
| Biomarker |
Reference Range |
Clinical Significance for Dosing |
| Serum B12 |
200–900 pg/mL (or 148–665 pmol/L) |
Foundational measure; low-normal may still indicate functional need for supplementation |
| Methylmalonic Acid (MMA) |
<0.4 mcmol/L |
Elevated MMA signals functional B12 deficiency; may require higher or more frequent dosing |
| Homocysteine |
<10 mcmol/L (optimal <8) |
Elevated levels indicate impaired methylation; B12 dosing should normalize this marker |
| Intrinsic Factor Antibodies |
Negative |
Positive result suggests pernicious anemia; injectable B12 bypasses absorption issues and guides dose need |
Metabolic Factors That Drive Dose Individualization
B12 demands increase with metabolic rate, stress, thyroid function, and energy demands. Individuals with high physical activity, intense cognitive work, or chronic stress may require higher or more frequent dosing. Genetic variations in methylation pathways and B12 metabolism also influence how efficiently your body utilizes supplemental B12.
Absorption capacity matters significantly. Patients with digestive conditions (pernicious anemia, celiac disease, Crohn's disease), gastrointestinal surgery history, or certain medications (metformin, proton pump inhibitors) benefit from injectable MIC B12 because it bypasses oral absorption barriers. These populations often need higher or more frequent doses.
Safety Considerations and Provider Oversight
MIC B12 injections are water-soluble and excess amounts are typically excreted; true toxicity is rare. However, over-supplementation may cause headaches, anxiety, or sleep disturbances in sensitive individuals. Starting at conservative doses and titrating upward under provider guidance prevents unnecessary side effects.
Certain conditions warrant cautious dosing or provider clearance: undiagnosed neurological symptoms, polycythemia vera, Leber's disease, or concurrent high-dose folate supplementation. A qualified healthcare provider should evaluate baseline health status, medication interactions, and symptom response before adjusting MIC B12 protocols.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context around metabolic variants affecting B12 utilization and methylation capacity. Genetic variants in methionine synthase, methylenetetrahydrofolate reductase (MTHFR), and homocysteine metabolism pathways influence how efficiently your body processes B12, informing whether standard or optimized dosing may be more appropriate.
The genetic test reveals predispositions in nutrient absorption and energy metabolism pathways—not exact B12 response or dose prediction. Results should be interpreted with a qualified healthcare provider to contextualize whether your genetic background suggests a higher metabolic demand for B12 or potential absorption challenges.
Understanding your genetic predispositions in methylation and B12 metabolism can support a more informed conversation with your provider about baseline biomarker testing, appropriate dosing strategy, and expected response timelines. This personalization approach moves beyond generic protocols toward precision wellness.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is MIC B12 dosing different from standard B12 injections?
MIC B12 combines methylcobalamin, inositol, and choline. Dosing principles remain similar (500–2500 mcg range), but the choline and inositol components support mitochondrial energy and metabolism, which some providers use to guide slightly different frequency protocols.
How often should I get MIC B12 injections?
Frequency depends on baseline B12 status and clinical goals. Initial protocols often use weekly injections for 4–8 weeks, then transition to biweekly or monthly maintenance. Your provider should adjust based on symptom response and repeat biomarker testing.
Can I take too much MIC B12?
B12 is water-soluble and excess amounts are typically excreted. However, over-supplementation may cause headaches, anxiety, or sleep issues in sensitive individuals. Start conservatively and let your provider adjust based on response rather than pursuing maximum doses.
What biomarkers should I check before starting MIC B12?
Request serum B12, methylmalonic acid (MMA), homocysteine, and complete metabolic panel. If pernicious anemia is suspected, intrinsic factor antibodies should also be tested. These baseline markers guide your provider's dosing recommendation.
Does PlexusDx offer genetic testing to personalize B12 dosing?
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on or $298 standalone), which reveals predispositions in methylation and nutrient metabolism pathways. Results may help contextualize B12 needs when discussed with your provider—though genetics does not predict exact dosing requirements.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can I Take 1: Genetic Predisposition and Clinical Eligibility
NAD+ Cost in 2026: Subscription Pricing and Out-of-Pocket Ranges